These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 82617)
1. Benzopyrones. 14. Synthesis and antiallergic properties of some N-tetrazolylcarboxamides and related compounds. Ellis GP; Becket GJ; Shaw D; Wilson HK; Vardey CJ; Skidmore IF J Med Chem; 1978 Nov; 21(11):1120-6. PubMed ID: 82617 [TBL] [Abstract][Full Text] [Related]
2. Antiallergic effects of 4-[2-oxo-3-(1H-tetrazol-5-yl)-2H-chromen-8-yloxy]-bu tyric acid. Kuriyama K; Hiyama Y; Ito K Jpn J Pharmacol; 1989 Jun; 50(2):111-8. PubMed ID: 2475659 [TBL] [Abstract][Full Text] [Related]
3. Studies on antiallergic agents. I. Phenyl-substituted heterocycles with a 5-tetrazolyl or N-(5-tetrazolyl)carbamoyl group. Honma Y; Sekine Y; Hashiyama T; Takeda M; Ono Y; Tsuzurahara K Chem Pharm Bull (Tokyo); 1982 Dec; 30(12):4314-24. PubMed ID: 7168865 [No Abstract] [Full Text] [Related]
4. Synthesis and quantitative structure-activity relationships of antiallergic 2-hydroxy-N-1H-tetrazol-5-ylbenzamides and N-(2-hydroxyphenyl)-1H-tetrazole-5-carboxamides. Ford RE; Knowles P; Lunt E; Marshall SM; Penrose AJ; Ramsden CA; Summers AJ; Walker JL; Wright DE J Med Chem; 1986 Apr; 29(4):538-49. PubMed ID: 2870188 [TBL] [Abstract][Full Text] [Related]
5. 3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new antiallergic agent. Peet NP; Baugh LE; Sunder S; Lewis JE; Matthews EH; Olberding EL; Shah DN J Med Chem; 1986 Nov; 29(11):2403-9. PubMed ID: 2431144 [TBL] [Abstract][Full Text] [Related]
6. Benzopyrones. 7. Synthesis and antiallergic activity of some 2-(5-tetrazolyl)chromones. Ellis GP; Shaw D J Med Chem; 1972 Aug; 15(8):865-7. PubMed ID: 5044310 [No Abstract] [Full Text] [Related]
7. Studies on antianaphylactic agents. 5. Synthesis of 3-(1H-tetrazol-5-yl)chromones, a new series of antiallergic substances. Nohara A; Kuriki H; Saijo T; Sugihara H; Kanno M; Sanno Y J Med Chem; 1977 Jan; 20(1):141-5. PubMed ID: 13214 [TBL] [Abstract][Full Text] [Related]
8. Effects of quinotolast, a new orally active antiallergic drug, on experimental allergic models. Kobayashi K; Hiroi J; Kishi S; Sawase K; Hirayama Y; Chihara S; Imai T; Shigi Y; Shimomura K; Kohsaka M Jpn J Pharmacol; 1993 Sep; 63(1):73-81. PubMed ID: 7505860 [TBL] [Abstract][Full Text] [Related]
9. CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy. Adolphson RL; Finkel MP; Robichaud LJ Int J Immunopharmacol; 1987; 9(1):51-60. PubMed ID: 2438239 [TBL] [Abstract][Full Text] [Related]
10. Antiallergic activity of tiaramide (RHC 2592-A). Khandwala A; Coutts S; Weinryb I Int Arch Allergy Appl Immunol; 1982; 69(2):159-68. PubMed ID: 6179887 [TBL] [Abstract][Full Text] [Related]
11. Anti-allergic activities of a new benzopyranopyridine derivative Y-12,141 in rats. Goto K; Terasawa M; Maruyama Y Int Arch Allergy Appl Immunol; 1979; 59(1):13-9. PubMed ID: 87373 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of 2-(2,3-dihydro-2-oxo-1,3,4-oxadiazol-5-yl) benzo heterocycles. A novel series of orally active antiallergic agents. Musser JH; Brown RE; Loev B; Bailey K; Jones H; Kahen R; Huang FC; Khandwala A; Leibowitz M; Sonnino-Goldman P J Med Chem; 1984 Feb; 27(2):121-5. PubMed ID: 6198518 [TBL] [Abstract][Full Text] [Related]
13. Nitrogen bridgehead compounds. 18. New antiallergic 4H-pyrido[1,2-a]pyrimidin-4-ones. 1. Hermecz I; Breining T; Mészáros Z; Horváth A; Vasvári-Debreczy L; Dessy F; DeVos C; Rodriguez L J Med Chem; 1982 Oct; 25(10):1140-5. PubMed ID: 6183427 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiallergic activity of some acidic derivatives of 4H-pyrimido[2,1-b]benzazol-4-ones. Wade JJ; Toso CB; Matson CJ; Stelzer VL J Med Chem; 1983 Apr; 26(4):608-11. PubMed ID: 6834395 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414. Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252 [TBL] [Abstract][Full Text] [Related]
17. Disodium cromoglycate. Mode of action and its possible relevance to the clinical use of the drug. Cox JS Br J Dis Chest; 1971 Oct; 65(4):189-204. PubMed ID: 4400180 [No Abstract] [Full Text] [Related]
18. Antiallergic properties of SQ 13,847, an orally effective agent. II. Activity in vitro. Free CA; Hall LE J Pharmacol Exp Ther; 1980 Jun; 213(3):437-40. PubMed ID: 6162946 [TBL] [Abstract][Full Text] [Related]
19. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate. Nabe T; Yamamura H; Kohno S; Ohata K Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084 [TBL] [Abstract][Full Text] [Related]
20. Studies on antiulcer agents. II. Antiulcer properties of N-(1H-tetrazol-5-yl)-2-anilino-5-pyrimidinecarboxamides inhibiting release of histamine from passively sensitized rat peritoneal mast cells. Terashima K; Tanimura T; Shimamura H; Kawase A; Uenishi K; Tanaka Y; Kimura I; Kamisaki T; Ishizuka Y; Sato M Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1042-4. PubMed ID: 7543824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]